Mengru Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Cell Cycle Arrest

Ischemia Reperfusion Injury

Top Venues

ACS pharmacology & translational science

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mengru Li, Fan Cao, Weijie Wang, Yulei Ma, Zhihui Yu, Ke Wang, Ying Chen, Hongrui Liu
Coumarin-Furoxan Hybrid Suppressed the Proliferation and Metastasis of Triple-Negative Breast Cancer by Activating Mitochondrial Stress and Cell Apoptosis. ACS pharmacology & translational science 7 (5) (2024)
Mengru Li, Fan Cao, Weijie Wang, Yulei Ma, Zhihui Yu, Ke Wang, Ying Chen, Hongrui Liu
Coumarin-Furoxan Hybrid Suppressed the Proliferation and Metastasis of Triple-Negative Breast Cancer by Activating Mitochondrial Stress and Cell Apoptosis. ACS pharmacology & translational science 7 (5) (2024)
Zhihui Yu, Mengru Li, Ke Wang, Yuting Gu, Shiqi Guo, Weijie Wang, Yulei Ma, Hongrui Liu, Ying Chen
Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR. Journal of medicinal chemistry 65 (13) (2022)
Zhihui Yu, Mengru Li, Shiqi Guo, Weijie Wang, Feng Qu, Yulei Ma, Hongrui Liu, Ying Chen
Novel Nitric Oxide Donor Dinitroazetidine-Coumarin Hybrids as Potent Anti-Intrahepatic Cholangiocarcinoma Agents. Molecules (Basel, Switzerland) 27 (13) (2022)